How Common Is Convergence Insufficiency? The Data

Search for how common convergence insufficiency is and the answers will not agree. Depending on how the condition is defined and who was examined, published figures run from about 3% of randomly sampled young adults (Garcia-Munoz et al., 2016) to nearly 18% of children already attending an optometry clinic (Rouse et al., 1998) — and higher still in concussion clinics. That spread is not sloppiness. It is the honest result of researchers using different definitions, in different populations, for different purposes. Here is what the studies actually measured, and what the numbers mean for you.

Key takeaways

• There is no single prevalence figure, because there is no single agreed definition. A recent review puts convergence insufficiency at roughly 7.5% of the population while noting that criteria range from one clinical sign to many (Gantz & Stiebel-Kalish, 2022).
• In US fifth- and sixth-graders, about 13% met a high-suspect or definite definition; only 4.2% met the strictest three-sign definition (Rouse et al., 1999).
• In children already attending optometry clinics, the figure was 17.6% (Rouse et al., 1998).
• Signs and symptoms do not track together. About 10% of young adults who thought their vision was normal met the criteria, and two-thirds of them had no significant symptoms (Horwood et al., 2014).
• After concussion, the numbers rise sharply in referral samples: convergence insufficiency in 49% of adolescents in one concussion program (Master et al., 2016).

The definition changes the number

Convergence insufficiency is not diagnosed from one test. It is a pattern: a receded near point of convergence, an eye posture that drifts outward more at near than at distance, and reduced ability to converge on demand. Studies differ on how many of those signs a child must have.

The original school study sorted children into three separate groups — low-suspect (one sign), high-suspect (two signs) and definite (three signs) — so the prevalence you quote depends entirely on where you set the bar. The paper reports 4.2% definite, 8.8% high-suspect and 8.4% low-suspect, and its own headline figure of 13% combines the definite and high-suspect groups (Rouse et al., 1999). Add the low-suspect group in as well and 21.4% of the children have at least one sign — that last figure is our arithmetic on the paper’s groups, not a number the authors quote. Nothing about the children changed — only the threshold did.

This is not just a research problem. A review of 387 patient charts from fellowship-trained strabismus specialists found no uniformity in how the diagnosis was made, with near point of convergence amplitudes highly variable and most clinicians not performing convergence fusional amplitude testing (Lavrich et al., 2019). When you see a prevalence figure quoted without its definition, treat it as incomplete.

School-age children in the United States

The most-quoted US figure comes from 453 fifth- and sixth-graders examined in a school-based study: 4.2% definite, 8.8% high-suspect and 8.4% low-suspect convergence insufficiency, which the authors summarised as about 13% for the combined high-suspect and definite groups (Rouse et al., 1999).

One thing to keep in mind when reading that number: those 453 children were a screened subset. To be measured, a child needed 20/30 or better acuity, minimal refractive error, no strabismus and exophoria at near. In a post whose whole argument is that definitions drive the number, the entry criteria count as part of the definition.

Another detail in that paper matters clinically. Among children with all three convergence signs, 78.9% also had accommodative insufficiency — trouble sustaining focus at near. Eye teaming and focusing problems travel together, which is why an evaluation should test both.

Children in eye clinics: about one in six

Prevalence changes with the setting. Among 415 children aged 8 to 12 seen in two optometry clinics, 17.6% had clinically significant convergence insufficiency, and the proportion rated symptomatic climbed as the number of signs went up (Rouse et al., 1998).

Clinic figures run higher than school figures for an obvious reason: children arrive at an eye clinic because something prompted the visit. That is referral bias, not a contradiction. Both numbers are correct for the group they describe.

Outside the United States

A large school study in Tamil Nadu, India, examined 920 children aged 7 to 17 and found non-strabismic binocular vision anomalies in about 30%, with convergence insufficiency the most common single anomaly at 16.5% in urban and 17.6% in rural schools. Taking all of those anomalies together, prevalence was higher in 13- to 17-year-olds (36.2%) than in 7- to 12-year-olds (25.1%) (Hussaindeen et al., 2017). Those cut-offs were derived locally, so the figures should not be transplanted directly onto US children — but the age gradient is worth noticing, since near-work demand rises through middle and high school.

Adults: signs and symptoms come apart

The most useful adult study recruited 167 university students whose main qualification was that they believed their eyesight was normal. Seventeen of them (10%) met the criteria for convergence insufficiency — and 11 of those 17 (65%) had no significant symptoms. Meanwhile 41 students (25%) returned high symptom scores, but only 6 of those 41 (15%) had genuine convergence insufficiency (Horwood et al., 2014).

Two conclusions follow. Eye-teaming signs can exist quietly. And near-work symptoms are common in adults for many reasons that have nothing to do with convergence. A study of 175 randomly sampled university students found symptomatic accommodative or binocular dysfunction in 13.15% overall, with convergence insufficiency the most common single diagnosis at 3.43% (Garcia-Munoz et al., 2016).

The Convergence Insufficiency Symptom Survey is the standard questionnaire in this literature, with a cut-off of 16 or more in children (Borsting et al., 2003) and 21 or more in adults (Rouse et al., 2004). It was built as the primary outcome measure for treatment trials. The children’s validation paper concludes it is valid for children aged 9 to 18 enrolled in clinical research; the adult paper goes further and concludes it can be used clinically as well as for research in adults with convergence insufficiency. What it is not is a stand-alone screening test for an unselected population — in the university study above, a high score was right only 15% of the time.

After a concussion, the numbers jump

In concussion referral clinics the picture changes. Among 100 adolescents aged 11 to 17 in a comprehensive concussion program, 69% had at least one vision diagnosis: accommodative disorders 51%, convergence insufficiency 49% and saccadic dysfunction 29% (Master et al., 2016). In 113 adolescents examined four to twelve weeks after injury, 70% had an oculomotor diagnosis and 35% specifically had convergence insufficiency, while physician screening had limited sensitivity for detecting them — 63% for near point of convergence and 43% for accommodative amplitude (Scheiman et al., 2021). Acutely, about 42% of concussed athletes tested around six days post-injury had a receded near point of convergence (Pearce et al., 2015), and among adults two to six months after concussion, 20.4% had symptomatic convergence insufficiency (Nisted et al., 2024).

These are referral samples, not all concussions, and time matters. Of 67 children with abnormal near point of convergence after concussion, 46% recovered with standard care at a median of about four and a half weeks, a further 41% recovered after vestibular therapy that included convergence exercises such as Brock string and pencil push-ups, and 13% with persistent findings were referred for office-based vision therapy (Storey et al., 2017). So most children did recover convergence — but well over a third of them recovered with therapy that specifically worked on convergence, not by waiting. The AAP/AAO/AAPOS/AACO clinical report reflects the same shape: most children recover by four weeks, and those who do not warrant a vision-specific history and examination (Master et al., 2022). More on this at concussions.

What the prevalence data should change

Even at the strictest definition, convergence insufficiency is not a rare finding. Of the fifth- and sixth-graders in the school study, 4.2% met the three-sign definition (Rouse et al., 1999), and 3.43% of randomly sampled university students had symptomatic convergence insufficiency (Garcia-Munoz et al., 2016). For scale, the USPSTF puts amblyopia or its risk factors — the target preschool vision screening was designed around — at 1% to 6% of children under six (USPSTF, 2017). These are different conditions in different age groups, so this is not a ranking. It is a reminder that screening is designed to catch one of them and not the other.

That design gap is measurable. The AOA’s pediatric guideline reports that Snellen acuity alone missed 75.5% of children later found to have binocular and oculomotor problems on complete examination, and that only 38.7% of children who failed a screening received follow-up care (AOA, 2017). Both things can be true at once: the screening is worth doing, and it is not designed to answer this question. We wrote more about that in what school vision screenings miss.

Professional bodies agree the condition is real and treatable. The American Academy of Ophthalmology’s Esotropia and Exotropia Preferred Practice Pattern states that convergence insufficiency occurs in children and adults and that symptoms with near viewing can often be improved using vergence exercises (AAO, 2022).

Our clinical perspective at Vision & Learning Center is that prevalence is a reason to look, not a diagnosis. What we treat is symptomatic convergence insufficiency, because that is what the strongest evidence supports: office-based vergence and accommodative therapy produced a successful or improved outcome in 73% of children versus 35% with office placebo (CITT, 2008). We are equally clear about the limits — the largest trial of the reading question found no advantage over placebo for reading comprehension (CITT-ART, 2019). For the full picture of both trials, see what the CITT and CITT-ART trials actually found, and for the condition itself, our overview of convergence insufficiency symptoms, diagnosis and treatment.

If your child skips lines, gets headaches after twenty minutes of homework, or covers one eye to read — or if reading has become uncomfortable for you as an adult — the base rate is beside the point. Run through our symptom checklist and then have the eyes measured, not guessed at. Schedule an evaluation and we will test convergence, focusing and eye movements directly.